4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-
(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole

상품명칭:	4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4- (trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
CAS 레지스트리 번호:	366017-09-6
동의어:	4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4- (trifluoromethyl)phenyl]ethenyl]-1,3-oxazole; TAK165; Mubritinib - TAK 165; Mubritinib; S2216_Selleck; SureCN94943; UNII-V734AZP9BR; Mubritinib (USAN/INN);366017-09-6; TAK 165;
분자 구조:
분자식:	C₂₅H₂₃F₃N₄O₂
분자량:	468.47093
밀도:	1.25g/cm³
비등점:	620.9°Cat760mmHg
굴절률:	1.577

4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole